{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:46:53Z","timestamp":1792324013444,"version":"4.4.0"},"reference-count":195,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>JAK\/STAT signaling pathway is one of the important regulatory signaling cascades for the myriad of cellular processes initiated by various types of ligands such as growth factors, hormones, and cytokines. The physiological processes regulated by JAK\/STAT signaling are immune regulation, cell proliferation, cell survival, apoptosis and hematopoiesis of myeloid and non-myeloid cells. Dysregulation of JAK\/STAT signaling is reported in various immunological disorders, hematological and other solid malignancies through various oncogenic activation mutations in receptors, downstream mediators, and associated transcriptional factors such as STATs. STATs typically have a dual role when explored in the context of cancer. While several members of the STAT family are involved in malignancies, however, a few members which include STAT3 and STAT5 are linked to tumor initiation and progression. Other STAT members such as STAT1 and STAT2 are pivotal for antitumor defense and maintenance of an effective and long-term immune response through evolutionarily conserved programs. The effects of JAK\/STAT signaling and the persistent activation of STATs in tumor cell survival; proliferation and invasion have made the JAK\/STAT pathway an ideal target for drug development and cancer therapy. Therefore, understanding the intricate JAK\/STAT signaling in the pathogenesis of solid malignancies needs extensive research. A better understanding of the functionally redundant roles of JAKs and STATs may provide a rationale for improving existing cancer therapies which have deleterious effects on normal cells and to identifying novel targets for therapeutic intervention in solid malignancies.<\/jats:p>","DOI":"10.3389\/fphar.2022.821344","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:12:16Z","timestamp":1648516336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":165,"title":["JAK\/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies"],"prefix":"10.3389","volume":"13","author":[{"given":"Bilal","family":"Rah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafiq A","family":"Rather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gh Rasool","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Basit","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifra","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzamil","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahira","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf B","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabra","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukhsana","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fozia","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqbal","family":"Qassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abida","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahrukh Hamid","family":"Zargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dil","family":"Afroze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.22074\/cellj.2015.1","article-title":"STATs: an Old story, yet Mesmerizing","volume":"17","author":"Abroun","year":"2015","journal-title":"Cell J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e136176","DOI":"10.1172\/jci.insight.136176","article-title":"Potent Antitumor Effects of Cell-Penetrating Peptides Targeting STAT3 axis","volume":"6","author":"Aftabizadeh","year":"2021","journal-title":"JCI insight"},{"key":"B3","doi-asserted-by":"publisher","first-page":"699044","DOI":"10.3389\/fphar.2021.699044","article-title":"Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus\u2013Driven Head and Neck Cancer: Current Evidence and Future Prospects","volume":"12","author":"Aggarwal","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nrdp.2017.36","article-title":"Gastric Adenocarcinoma","volume":"3","author":"Ajani","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3390\/medicina55090526","article-title":"Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies","volume":"55","author":"Alqahtani","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3390\/cells8080898","article-title":"Pathogenic and Therapeutic Relevance of JAK\/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the prospect of Their Inhibition with an Oral Agent","volume":"8","author":"Alunno","year":"2019","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e20180160","DOI":"10.1590\/1678-4685-gmb-2018-0160","article-title":"Targeting STAT-3 Signaling Pathway in Cancer for Development of Novel Drugs: Advancements and Challenges","volume":"43","author":"Arshad","year":"2020","journal-title":"Genet. Mol. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-64550-6_5","article-title":"Cancer Genetics at a Glance: The Comprehensive Insights","volume":"5","author":"Azarnezhad","year":"2017","journal-title":"Cancer Genet. Psychotherapy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"118999","DOI":"10.1016\/j.lfs.2020.118999","article-title":"Polyphenolic Molecules Targeting Signal Transducer and Activator of Transcription 3 Pathway for the Treatment of Cancer","volume":"268","author":"Aziz","year":"2021","journal-title":"Life Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1093\/eurheartj\/ehab447","article-title":"The JAK-STAT Pathway: an Emerging Target for Cardiovascular Disease in Rheumatoid Arthritis and Myeloproliferative Neoplasms","volume":"42","author":"Baldini","year":"2021","journal-title":"Eur. Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/ijc.29923","article-title":"Constitutive Activation of STAT3 in Breast Cancer Cells: A Review","volume":"138","author":"Banerjee","year":"2016","journal-title":"Int. J. Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/1748-5967.12384","article-title":"JAK\/STAT Signaling in Insect Innate Immunity","volume":"49","author":"Bang","year":"2019","journal-title":"Entomol. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"98S","DOI":"10.1177\/2192568219830323","article-title":"Essential Concepts for the Management of Metastatic Spine Disease: what the Surgeon Should Know and Practice","volume":"9","author":"Barzilai","year":"2019","journal-title":"Glob. Spine J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.06.006","article-title":"Two Decades of Research in Discovery of Anticancer Drugs Targeting STAT3, How Close Are We","volume":"191","author":"Beebe","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1008824","DOI":"10.1080\/2162402X.2015.1008824","article-title":"Interferon-\u03b3-induced Activation of JAK1 and JAK2 Suppresses Tumor Cell Susceptibility to NK Cells through Upregulation of PD-L1 Expression","volume":"4","author":"Bellucci","year":"2015","journal-title":"Oncoimmunology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-3-319-42949-6_5","article-title":"STAT3 Inhibitors in Cancer: A Comprehensive Update","volume":"5","author":"Bharadwaj","year":"2016","journal-title":"STAT. Inhibitors Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pharmthera.2017.02.011","article-title":"Epigenetics in Cancer: Fundamentals and beyond","volume":"173","author":"Biswas","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.4251\/wjgo.v11.i10.804","article-title":"Precision Medicine in Gastric Cancer","volume":"11","author":"Bonelli","year":"2019","journal-title":"World J. Gastrointest. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/13543784.2017.1323871","article-title":"Investigational Janus Kinase Inhibitors in Development for Myelofibrosis","volume":"26","author":"Bose","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/cells9061451","article-title":"Targeting the JAK\/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy","volume":"9","author":"Bose","year":"2020","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fonc.2018.00287","article-title":"\u201cDo We Know jack\u201d about JAK? A Closer Look at JAK\/STAT Signaling Pathway","volume":"8","author":"Bousoik","year":"2018","journal-title":"Front. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1182\/blood-2018-99-118158","article-title":"Sf3b1 Regulation of Jak\/Stat Signaling Is Essential for Hematopoietic Stem Cell Formation","volume":"132","author":"Bowman","year":"2018","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/cancers11101618","article-title":"A Comprehensive Review on MAPK: a Promising Therapeutic Target in Cancer","volume":"11","author":"Braicu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/onc.2015.150","article-title":"Targeting JAK Kinase in Solid Tumors: Emerging Opportunities and Challenges","volume":"35","author":"Buchert","year":"2016","journal-title":"Oncogene"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0202-2","article-title":"Beyond EGFR Inhibition: Multilateral Combat Strategies to Stop the Progression of Head and Neck Cancer","volume":"51","author":"Byeon","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4252\/wjsc.v7.i1.27","article-title":"Cancer Stem Cell Plasticity and Tumor Hierarchy","volume":"7","author":"Cabrera","year":"2015","journal-title":"World J. Stem Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"44976","DOI":"10.18632\/oncotarget.16689","article-title":"Thalidomide Combined with Transcatheter Artierial Chemoembolzation for Primary Hepatocellular Carcinoma: a Systematic Review and Meta-Analysis","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.pharmthera.2015.10.004","article-title":"Targeting Transcription Factor STAT3 for Cancer Prevention and Therapy","volume":"162","author":"Chai","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cam4.1274","article-title":"Medical Management of Gastric Cancer: a 2017 Update","volume":"7","author":"Charalampakis","year":"2018","journal-title":"Cancer Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","article-title":"Regulating Tumor Suppressor Genes: post-translational Modifications","volume":"5","author":"Chen","year":"2020","journal-title":"Signal. Transduct Target. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/978-3-030-69852-2_7","article-title":"Proinflammatory Signaling Pathways and Genomic Signatures in Head and Neck Cancers","volume":"143","author":"Chen","year":"2021","journal-title":"Early Detect. Treat. Head Neck Cancers: Theor. Background Newly Emerging Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.3892\/or.2019.7071","article-title":"Rab1A Promotes Proliferation and Migration Abilities via Regulation of the HER2\/AKT-independent mTOR\/S6K1 Pathway in Colorectal Cancer","volume":"41","author":"Cheng","year":"2019","journal-title":"Oncol. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/annonc\/mdw040","article-title":"Molecular Classification of Gastric Cancer","volume":"27","author":"Chia","year":"2016","journal-title":"Ann. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10068-017-0001-x","article-title":"An Updated Review on Molecular Mechanisms Underlying the Anticancer Effects of Capsaicin","volume":"26","author":"Cho","year":"2017","journal-title":"Food Sci. Biotechnol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00280-017-3501-8","article-title":"Advances in Ovarian Cancer Therapy","volume":"81","author":"Cortez","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000501145","article-title":"Fibroblast Growth Factors: a Controlling Mechanism of Skin Aging","volume":"4","author":"de Ara\u00fajo","year":"2019","journal-title":"Skin Pharmacol. Physiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tem.2017.11.001","article-title":"JAK\/STAT - Emerging Players in Metabolism","volume":"29","author":"Dodington","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41419-020-03189-z","article-title":"Exosomes and Breast Cancer Drug Resistance","volume":"11","author":"Dong","year":"2020","journal-title":"Cell Death Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","article-title":"Mechanisms of Receptor Tyrosine Kinase Activation in Cancer","volume":"17","author":"Du","year":"2018","journal-title":"Mol. Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","article-title":"Turning Cold into Hot: Firing up the Tumor Microenvironment","volume":"6","author":"Duan","year":"2020","journal-title":"Trends Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jhep.2016.10.029","article-title":"Tremelimumab in Combination with Ablation in Patients with Advanced Hepatocellular Carcinoma","volume":"66","author":"Duffy","year":"2017","journal-title":"J. Hepatol."},{"key":"B43","article-title":"Mechanisms of Multicellular Drug Resistance and Novel Approaches for Targeted Therapy in Cancer","author":"Edsb\u00e4cker","year":"2019"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1038\/s41467-019-10676-1","article-title":"IL-33-mediated Mast Cell Activation Promotes Gastric Cancer through Macrophage Mobilization","volume":"10","author":"Eissmann","year":"2019","journal-title":"Nat. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/15384047.2016.1210733","article-title":"Anticancer Potential of Diarylidenyl Piperidone Derivatives, HO-4200 and H-4318, in Cisplatin Resistant Primary Ovarian Cancer","volume":"17","author":"ElNaggar","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2174\/0929867328666210628131409","article-title":"Natural Products as a Promising Therapeutic Strategy to Target Cancer Stem Cells","volume":"29","author":"Erkisa","year":"2021","journal-title":"Curr. Med. Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.str.2016.03.023","article-title":"The Structural Basis for Class II Cytokine Receptor Recognition by JAK1","volume":"24","author":"Ferrao","year":"2016","journal-title":"Structure"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-021-00770-7","article-title":"The Tyrosine Phosphatase SHP2 Increases Robustness and Information Transfer within IL-6-induced JAK\/STAT Signalling","volume":"19","author":"Fiebelkow","year":"2021","journal-title":"Cell Commun. Signaling"},{"key":"B49","doi-asserted-by":"publisher","first-page":"eaal2380","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic Plasticity and the Hallmarks of Cancer","volume":"357","author":"Flavahan","year":"2017","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13046-019-1396-4","article-title":"From Bench to Bed: the Tumor Immune Microenvironment and Current Immunotherapeutic Strategies for Hepatocellular Carcinoma","volume":"38","author":"Fu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-662-49672-5_1","article-title":"\u201cBenign and Potentially Malignant Lesions of the Squamous Epithelium and Squamous Cell Carcinoma","volume":"1","author":"Gale","year":"2016","journal-title":"Pathol. Head Neck"},{"key":"B52","doi-asserted-by":"publisher","first-page":"12059","DOI":"10.3748\/wjg.v21.i42.12059","article-title":"Sorafenib-based Combined Molecule Targeting in Treatment of Hepatocellular Carcinoma","volume":"21","author":"Gao","year":"","journal-title":"World J. Gastroenterol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3892\/ol.2014.2694","article-title":"Synergistic Effects of Curcumin and Bevacizumab on Cell Signaling Pathways in Hepatocellular Carcinoma","volume":"9","author":"Gao","year":"","journal-title":"Oncol. Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e1007707","DOI":"10.1371\/journal.pgen.1007707","article-title":"A Survey of Inter-individual Variation in DNA Methylation Identifies Environmentally Responsive Co-regulated Networks of Epigenetic Variation in the Human Genome","volume":"14","author":"Garg","year":"2018","journal-title":"Plos Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jcar.JCar_9_16","article-title":"Review of Hepatocellular Carcinoma: Epidemiology, Etiology, and Carcinogenesis","volume":"16","author":"Ghouri","year":"2017","journal-title":"J. carcinogenesis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/biomedicines9080889","article-title":"NF-\u03baB and Human Cancer: What Have We Learned over the Past 35 years?","volume":"9","author":"Gilmore","year":"2021","journal-title":"Biomedicines"},{"key":"B57","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1517\/14728222.2012.709238","article-title":"Targeting STAT3 in Gastric Cancer","volume":"16","author":"Giraud","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"B58","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3892\/ol.2016.4614","article-title":"JNK1\/2 Expression and Modulation of STAT3 Signaling in Oral Cancer","volume":"12","author":"Gkouveris","year":"2016","journal-title":"Oncol. Lett."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2017.05.033","article-title":"Jak Stat Signaling and Cancer: Opportunities, Benefits and Side Effects of Targeted Inhibition","volume":"451","author":"Groner","year":"2017","journal-title":"Mol. Cel Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3892\/ijmm.2016.2692","article-title":"Targeted Blockade of JAK\/STAT3 Signaling Inhibits Proliferation, Migration and Collagen Production as Well as Inducing the Apoptosis of Hepatic Stellate Cells","volume":"38","author":"Gu","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08977194.2018.1473393","article-title":"STAT3: a Multifaceted Oncoprotein","volume":"36","author":"Guanizo","year":"2018","journal-title":"Growth Factors"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3390\/cells9102297","article-title":"Role of the JAK\/STAT Pathway in Cervical Cancer: its Relationship with HPV E6\/E7 Oncoproteins","volume":"9","author":"Guti\u00e9rrez-Hoya","year":"2020","journal-title":"Cells"},{"key":"B63","article-title":"Increased Estrogen Receptor Expression Leads to a Novel DNA Binding Signature Which Differentiates Luminal A and Luminal B Breast Cancers","author":"Haddon","year":"2018"},{"key":"B64","doi-asserted-by":"publisher","first-page":"5152072","DOI":"10.1155\/2019\/5152072","article-title":"Apatinib Promotes Apoptosis of Pancreatic Cancer Cells through Downregulation of Hypoxia-Inducible Factor-1\u03b1 and Increased Levels of Reactive Oxygen Species","volume":"2019","author":"He","year":"2019","journal-title":"Oxidative Med. Cell. longevity"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jvir.2018.03.027","article-title":"Comparison of Stable and Unstable Ethiodized Oil Emulsions for Transarterial Chemoembolization of Hepatocellular Carcinoma: Results of a Single-center Double-Blind Prospective Randomized Controlled Trial","volume":"29","author":"He","year":"2018","journal-title":"J. Vasc. Interv. Radiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"HEP18","DOI":"10.2217\/hep-2020-0001","article-title":"JAK\/STAT Signaling in Hepatocellular Carcinoma","volume":"7","author":"Hin Tang","year":"2020","journal-title":"Hepat. Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/hepr.13243","article-title":"Therapeutic Potential of Lenvatinib for Unresectable Hepatocellular Carcinoma in Clinical Practice: Multicenter Analysis","volume":"49","author":"Hiraoka","year":"2019","journal-title":"Hepatol. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.apsb.2015.07.001","article-title":"Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors","volume":"5","author":"Huang","year":"2015","journal-title":"Acta Pharm. Sin B"},{"key":"B69","doi-asserted-by":"publisher","first-page":"111922","DOI":"10.1016\/j.ejmech.2019.111922","article-title":"Revisiting Signal Transducer and Activator of Transcription 3 (STAT3) as an Anticancer Target and its Inhibitor Discovery: Where Are We and where Should We Go?","volume":"187","author":"Huang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ejmech.2018.08.037","article-title":"Small-molecule Compounds Targeting the STAT3 DNA-Binding Domain Suppress Survival of Cisplatin-Resistant Human Ovarian Cancer Cells by Inducing Apoptosis","volume":"157","author":"Huang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fendo.2017.00361","article-title":"Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase","volume":"8","author":"Hubbard","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4254\/wjh.v9.i36.1305","article-title":"Molecular Basis of Hepatocellular Carcinoma Induced by Hepatitis C Virus Infection","volume":"9","author":"Irshad","year":"2017","journal-title":"World J. Hepatol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1201\/9780367811037-11","article-title":"Diseases of the Hepatobiliary Tree and Pancreas Associated with Fever","volume":"9","author":"Isaac","year":"2019","journal-title":"Unexplained Fever"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.18632\/oncotarget.13904","article-title":"Oxidative Stress, a Trigger of Hepatitis C and B Virus-Induced Liver Carcinogenesis","volume":"8","author":"Ivanov","year":"2017","journal-title":"Oncotarget"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.3389\/fonc.2020.604747","article-title":"Helicobacter pylori Subdues Cytokine Signaling to Alter Mucosal Inflammation via Hypermethylation of Suppressor of Cytokine Signaling 1 Gene during Gastric Carcinogenesis","volume":"10","author":"Jan","year":"2021","journal-title":"Front. Oncol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/febs.14343","article-title":"The Roles of CSFs on the Functional Polarization of Tumor-Associated Macrophages","volume":"285","author":"Jeannin","year":"2018","journal-title":"FEBS J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2147\/OTT.S187777","article-title":"Cryptotanshinone Inhibits Esophageal Squamous-Cell Carcinoma In Vitro and In Vivo through the Suppression of STAT3 Activation","volume":"12","author":"Ji","year":"2019","journal-title":"Onco Targets Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2021.8088","article-title":"Phlorizin from Sweet tea Inhibits the Progress of Esophageal Cancer by Antagonizing the JAK2\/STAT3 Signaling Pathway","volume":"46","author":"Jia","year":"2021","journal-title":"Oncol. Rep."},{"key":"B79","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of Hypoxia in Cancer Therapy by Regulating the Tumor Microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"B80","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cbi.2015.08.009","article-title":"Growth Factors Mediated Cell Signalling in Prostate Cancer Progression: Implications in Discovery of Anti-prostate Cancer Agents","volume":"240","author":"Joshi","year":"2015","journal-title":"Chem. Biol. Interact"},{"key":"B81","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.tips.2015.08.009","article-title":"Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease","volume":"36","author":"Kalimutho","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S1473-3099(17)30483-8","article-title":"The Global burden of Scabies: a Cross-Sectional Analysis from the Global Burden of Disease Study 2015","volume":"17","author":"Karimkhani","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s40425-019-0749-z","article-title":"Immunotherapy in Hepatocellular Carcinoma: the Complex Interface between Inflammation, Fibrosis, and the Immune Response","volume":"7","author":"Keenan","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/cells8080840","article-title":"Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies","volume":"8","author":"Khan","year":"","journal-title":"Cells"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2018.03.001","article-title":"RAS-mediated Oncogenic Signaling Pathways in Human Malignancies","volume":"54","author":"Khan","year":"","journal-title":"Semin. Cancer Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3892\/ijo.2015.3160","article-title":"The JAK\/STAT Signaling cascade in Gastric Carcinoma (Review)","volume":"47","author":"Khanna","year":"2015","journal-title":"Int. J. Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-017-0712-x","article-title":"The Biology of Hepatocellular Carcinoma: Implications for Genomic and Immune Therapies","volume":"16","author":"Khemlina","year":"2017","journal-title":"Mol. Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-319-66884-0_19","article-title":"Janus Kinase Inhibitors","volume":"19","author":"Kim","year":"2018","journal-title":"Biol. Systemic Agents Dermatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41467-017-02731-6","article-title":"Regulation of Chitinase-3-Like-1 in T Cell Elicits Th1 and Cytotoxic Responses to Inhibit Lung Metastasis","volume":"9","author":"Kim","year":"2018","journal-title":"Nat. Commun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e109114","DOI":"10.1371\/journal.pone.0109114","article-title":"Astaxanthin Inhibits JAK\/STAT-3 Signaling to Abrogate Cell Proliferation, Invasion and Angiogenesis in a Hamster Model of Oral Cancer","volume":"9","author":"Kowshik","year":"2014","journal-title":"PloS one"},{"key":"B91","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fendo.2020.00033","article-title":"Growth Hormone(s), Testosterone, Insulin-like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth with Exercise","volume":"11","author":"Kraemer","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3889\/oamjms.2015.032","article-title":"Challenging Role of Dietary Aflatoxin B1 Exposure and Hepatitis B Infection on Risk of Hepatocellular Carcinoma","volume":"3","author":"Kucukcakan","year":"2015","journal-title":"Open Access Maced J. Med. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1517\/13543776.2015.1086749","article-title":"A STAT Inhibitor Patent Review: Progress since 2011","volume":"25","author":"Lai","year":"2015","journal-title":"Expert Opin. Ther. Pat"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.3390\/cancers12113378","article-title":"The Non-coding Landscape of Cutaneous Malignant Melanoma: A Possible Route to Efficient Targeted Therapy","volume":"12","author":"Laz\u0103r","year":"2020","journal-title":"Cancers"},{"key":"B95","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejmech.2017.04.007","article-title":"Platinum, Palladium, Gold and Ruthenium Complexes as Anticancer Agents: Current Clinical Uses, Cytotoxicity Studies and Future Perspectives","volume":"142","author":"Lazarevi\u0107","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/cancers11111646","article-title":"STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma","volume":"11","author":"Lee","year":"2019","journal-title":"Cancers"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s00432-017-2466-7","article-title":"Overexpression of Glutathione Peroxidase 1 Predicts Poor Prognosis in Oral Squamous Cell Carcinoma","volume":"143","author":"Lee","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"101073","DOI":"10.1016\/j.redox.2018.101073","article-title":"Targeting STAT3 and Oxidative Phosphorylation in Oncogene-Addicted Tumors","volume":"25","author":"Lee","year":"2019","journal-title":"Redox Biol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1093\/carcin\/bgp211","article-title":"Guggulsterone Enhances Head and Neck Cancer Therapies via Inhibition of Signal Transducer and Activator of Transcription-3","volume":"30","author":"Leeman-Neill","year":"2009","journal-title":"Carcinogenesis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"837","DOI":"10.7150\/jca.35011","article-title":"STAT3 Signaling in Ovarian Cancer: a Potential Therapeutic Target","volume":"11","author":"Liang","year":"2020","journal-title":"J. Cancer"},{"key":"B101","doi-asserted-by":"publisher","first-page":"15763","DOI":"10.18632\/oncotarget.15000","article-title":"STAT3 Is Required for MiR-17-5p-Mediated Sensitization to Chemotherapy-Induced Apoptosis in Breast Cancer Cells","volume":"8","author":"Liao","year":"2017","journal-title":"Oncotarget"},{"key":"B102","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13046-018-0959-0","article-title":"The Natural Polyphenol Curcumin Induces Apoptosis by Suppressing STAT3 Signaling in Esophageal Squamous Cell Carcinoma","volume":"37","author":"Liu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fonc.2019.00048","article-title":"Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication","volume":"9","author":"Loh","year":"2019","journal-title":"Front. Oncol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/bs.apcsb.2018.11.007","article-title":"Activating Mutations of the gp130\/JAK\/STAT Pathway in Human Diseases","volume":"116","author":"Lokau","year":"2019","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1751-1097.2007.00254.x","article-title":"Understanding Signaling Cascades in Melanoma","volume":"84","author":"Lopez-Bergami","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3892\/mmr.2019.10474","article-title":"Dracorhodin Perchlorate Induces Apoptosis and G2\/M Cell Cycle Arrest in Human Esophageal Squamous Cell Carcinoma through Inhibition of the JAK2\/STAT3 and AKT\/FOXO3a Pathways","volume":"20","author":"Lu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"a022137","DOI":"10.1101\/cshperspect.a022137","article-title":"Signaling Cross Talk between TGF-\u03b2\/Smad and Other Signaling Pathways","volume":"9","author":"Luo","year":"2017","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3892\/ijo.2018.4308","article-title":"Apigenin Induces Apoptosis by Suppressing Bcl-Xl and Mcl-1 Simultaneously via Signal Transducer and Activator of Transcription 3 Signaling in colon Cancer","volume":"52","author":"Maeda","year":"2018","journal-title":"Int. J. Oncol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.oraloncology.2015.03.004","article-title":"Review of STAT3 (Signal Transducers and Activators of Transcription) in Head and Neck Cancer","volume":"51","author":"Mali","year":"2015","journal-title":"Oral Oncol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cbi.2014.03.001","article-title":"Possible Role of Selective, Irreversible, Proteasome Inhibitor (Carfilzomib) in the Treatment of Rat Hepatocellular Carcinoma","volume":"215","author":"Mansour","year":"2014","journal-title":"Chem. Biol. Interact"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/cancers12061398","article-title":"Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review","volume":"12","author":"Maoz","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B112","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12079-020-00548-5","article-title":"microRNA-141-3p-containing Small Extracellular Vesicles Derived from Epithelial Ovarian Cancer Cells Promote Endothelial Cell Angiogenesis through Activating the JAK\/STAT3 and NF-\u039ab Signaling Pathways","volume":"14","author":"Masoumi-Dehghi","year":"2020","journal-title":"J. Cel Commun Signal"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3748\/wjg.v24.i26.2818","article-title":"Biomarkers of Gastric Cancer: Current Topics and Future Perspective","volume":"24","author":"Matsuoka","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2217\/imt-2017-0134","article-title":"Modulation of Antitumor Immunity with Histone Deacetylase Inhibitors","volume":"9","author":"McCaw","year":"2017","journal-title":"Immunotherapy"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s43440-020-00156-5","article-title":"STAT3 Transcription Factor as Target for Anti-cancer Therapy","volume":"72","author":"Mohassab","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"B116","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/v12090977","article-title":"Manipulation of JAK\/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies","volume":"12","author":"Morgan","year":"2020","journal-title":"Viruses"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The Molecular Details of Cytokine Signaling via the JAK\/STAT Pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/vaccines4030026","article-title":"Leptin-induced JAK\/STAT Signaling and Cancer Growth","volume":"4","author":"Mullen","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"B119","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1002\/jcp.26289","article-title":"Molecular Mechanisms of Drug Resistance in Ovarian Cancer","volume":"233","author":"Norouzi-Barough","year":"2018","journal-title":"J. Cel Physiol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention","volume":"66","author":"O'Shea","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1053\/j.gastro.2015.08.054","article-title":"Recent Advances from Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma","volume":"149","author":"Ohashi","year":"2015","journal-title":"Gastroenterology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/biom9070270","article-title":"Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer","volume":"9","author":"Paulraj","year":"2019","journal-title":"Biomolecules"},{"key":"B123","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1158\/2159-8290.CD-17-0395","article-title":"Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma","volume":"8","author":"Pectasides","year":"2018","journal-title":"Cancer Discov."},{"key":"B124","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2016.06.017","article-title":"JAK-STAT Signaling in Cancer: From Cytokines to Non-coding Genome","volume":"87","author":"Pencik","year":"2016","journal-title":"Cytokine"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3892\/etm.2015.2749","article-title":"Biological and Therapeutic Activities, and Anticancer Properties of Curcumin","volume":"10","author":"Perrone","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-981-10-6728-0_12","article-title":"Role of STAT3 in Gastric Cancer Initiation, Development, and Progression","author":"Pinjari","year":"2017","journal-title":"Role Transcription Factors Gastrointest. Malignancies"},{"key":"B127","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/gutjnl-2020-321702","article-title":"Immunotherapy for Advanced Hepatocellular Carcinoma: a Focus on Special Subgroups","volume":"70","author":"Pinter","year":"2021","journal-title":"Gut"},{"key":"B128","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fonc.2015.00121","article-title":"STAT3-mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance","volume":"5","author":"Poli","year":"2015","journal-title":"Front. Oncol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.4254\/wjh.v7.i8.1054","article-title":"Percutaneous Microwave Ablation vs Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma","volume":"7","author":"Poulou","year":"2015","journal-title":"World J. Hepatol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41389-020-0195-2","article-title":"STAT3 Activates MSK1-Mediated Histone H3 Phosphorylation to Promote NFAT Signaling in Gastric Carcinogenesis","volume":"9","author":"Qi","year":"2020","journal-title":"Oncogenesis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a Potential Therapeutic Target in Triple Negative Breast Cancer: a Systematic Review","volume":"38","author":"Qin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"27","DOI":"10.20517\/2394-4722.2020.58","article-title":"Targeting the JAK\/STAT Pathway in Solid Tumors","volume":"6","author":"Qureshy","year":"2020","journal-title":"J. Cancer metastasis Treat."},{"key":"B133","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.3748\/wjg.v27.i36.6093","article-title":"Evaluation of Biomarkers, Genetic Mutations, and Epigenetic Modifications in Early Diagnosis of Pancreatic Cancer","volume":"27","author":"Rah","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1089\/jir.2015.0054","article-title":"STAT5 in Cancer and Immunity","volume":"36","author":"Rani","year":"2016","journal-title":"J. Interferon Cytokine Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1080\/10408398.2016.1263597","article-title":"Resveratrol as an Anti-cancer Agent: A Review","volume":"58","author":"Rauf","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2016.10.004","article-title":"IL-15 Signaling in NK Cell Cancer Immunotherapy","volume":"44","author":"Rautela","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cytogfr.2018.04.002","article-title":"Cross-talk between EGFR and IL-6 Drives Oncogenic Signaling and Offers Therapeutic Opportunities in Cancer","volume":"41","author":"Ray","year":"2018","journal-title":"Cytokine Growth Factor. Rev."},{"key":"B138","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1038\/s41388-019-0752-3","article-title":"Signal Transducer and Activator of Transcription (STAT)-5: An Opportunity for Drug Development in Oncohematology","volume":"38","author":"Recio","year":"2019","journal-title":"Oncogene"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2015.07.010","article-title":"A Historical Overview of Protein Kinases and Their Targeted Small Molecule Inhibitors","volume":"100","author":"Roskoski","year":"2015","journal-title":"Pharmacol. Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.semcancer.2015.08.003","article-title":"Mitogen-activated Protein Kinases and Hedgehog-GLI Signaling in Cancer: A Crosstalk Providing Therapeutic Opportunities","volume":"35","author":"Rovida","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"B195","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/cancers13030368","article-title":"In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors","volume":"13","author":"Roze","year":"2021","journal-title":"Cancers"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/carcin\/bgab075","article-title":"JAK\/STAT of All Trades: Linking Inflammation with Cancer Development, Tumor Progression and Therapy Resistance","volume":"42","author":"Sabaawy","year":"2021","journal-title":"Carcinogenesis"},{"key":"B142","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nrd.2017.267","article-title":"JAK Inhibition as a Therapeutic Strategy for Immune and Inflammatory Diseases","volume":"17","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"B143","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13046-019-1094-2","article-title":"Clinical Development of Targeted and Immune Based Anti-cancer Therapies","volume":"38","author":"Seebacher","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","article-title":"The Role of JAK-STAT Signaling Pathway and its Regulators in the Fate of T Helper Cells","volume":"15","author":"Seif","year":"2017","journal-title":"Cell Commun Signal"},{"key":"B145","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1517\/14728222.2011.648617","article-title":"Targeting the EGFR Signaling Pathway in Cancer Therapy","volume":"16","author":"Seshacharyulu","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1073274817729240","DOI":"10.1177\/1073274817729240","article-title":"The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer","volume":"24","author":"Shiani","year":"2017","journal-title":"Cancer control"},{"key":"B147","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12185-020-02964-0","article-title":"JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-4. Chronic Myeloid Leukemia (CML)\/myeloproliferative Neoplasms (MPN)","volume":"112","author":"Shimoda","year":"2020","journal-title":"Int. J. Hematol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s11899-019-00545-5","article-title":"Targeting the JAK\/STAT Pathway in T Cell Lymphoproliferative Disorders","volume":"14","author":"Shouse","year":"2019","journal-title":"Curr. Hematol. Malig Rep."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s12276-020-0445-6","article-title":"The JAK1\/STAT3\/SOCS3 axis in Bone Development, Physiology, and Pathology","volume":"52","author":"Sims","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.oraloncology.2016.07.013","article-title":"Oral Cancer: Deregulated Molecular Events and Their Use as Biomarkers","volume":"61","author":"Sinevici","year":"2016","journal-title":"Oral Oncol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/CMAR.S149619","article-title":"Gastric Cancer: Epidemiology, Prevention, Classification, and Treatment","volume":"10","author":"Sitarz","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbcan.2013.12.005","article-title":"Targeting the STAT3 Signaling Pathway in Cancer: Role of Synthetic and Natural Inhibitors","volume":"1845","author":"Siveen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B153","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.7150\/thno.18630","article-title":"MMPP Attenuates Non-small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity via Direct Binding to the STAT3 DNA-Binding Domain","volume":"7","author":"Son","year":"2017","journal-title":"Theranostics"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/mc.22438","article-title":"Non-canonical Stat3 Signaling in Cancer","volume":"55","author":"Srivastava","year":"2016","journal-title":"Mol. Carcinog"},{"key":"B155","doi-asserted-by":"publisher","first-page":"a028555","DOI":"10.1101\/cshperspect.a028555","article-title":"Responses to Cytokines and Interferons that Depend upon JAKs and STATs","volume":"10","author":"Stark","year":"2018","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1002\/ijc.30666","article-title":"Suppressor of Cytokine Signaling-1 Gene Therapy Induces Potent Antitumor Effect in Patient-Derived Esophageal Squamous Cell Carcinoma Xenograft Mice","volume":"140","author":"Sugase","year":"2017","journal-title":"Int. J. Cancer"},{"key":"B157","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A. Cancer J. Clin."},{"key":"B158","doi-asserted-by":"publisher","first-page":"e0116688","DOI":"10.1371\/journal.pone.0116688","article-title":"Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation","volume":"10","author":"Szelag","year":"2015","journal-title":"PloS one"},{"key":"B159","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tranon.2018.10.004","article-title":"Co-expression of VEGF and IL-6 Family Cytokines Is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-specific IL-6 Family Cytokine-Mediated VEGF Secretion","volume":"12","author":"Tawara","year":"2019","journal-title":"Transl Oncol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fphar.2019.00451","article-title":"MicroRNA post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies","volume":"10","author":"Tezcan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semcancer.2019.09.022","article-title":"Repurposing of Drugs as STAT3 Inhibitors for Cancer Therapy","volume":"68","author":"Thilakasiri","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.it.2019.11.008","article-title":"Epigenetic Regulation of T Cell Memory: Recalling Therapeutic Implications","volume":"41","author":"Tough","year":"2020","journal-title":"Trends Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3389\/fonc.2019.01148","article-title":"Immune System Evasion as Hallmark of Melanoma Progression: the Role of Dendritic Cells","volume":"9","author":"Tucci","year":"2019","journal-title":"Front. Oncol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12328-020-01237-x","article-title":"Epidemiology of Esophageal Cancer: Update in Global Trends, Etiology and Risk Factors","volume":"13","author":"Uhlenhopp","year":"2020","journal-title":"Clin. J. Gastroenterol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/c8lc00684a","article-title":"Cancer Diagnosis: from Tumor to Liquid Biopsy and beyond","volume":"19","author":"Vaidyanathan","year":"2019","journal-title":"Lab. Chip"},{"key":"B166","doi-asserted-by":"publisher","first-page":"82","DOI":"10.12688\/f1000research.13167.1","article-title":"JAK Inhibitors for the Treatment of Myeloproliferative Neoplasms and Other Disorders","volume":"7","author":"Vainchenker","year":"2018","journal-title":"F1000Research"},{"key":"B167","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.2147\/OTT.S142154","article-title":"The Crossroads of Breast Cancer Progression: Insights into the Modulation of Major Signaling Pathways","volume":"10","author":"Velloso","year":"2017","journal-title":"Onco Targets Ther."},{"key":"B168","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","article-title":"The Potential and Controversy of Targeting STAT Family Members in Cancer","volume":"60","author":"Verhoeven","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.7150\/ijbs.33710","article-title":"Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs","volume":"15","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"BSR20171175","DOI":"10.1042\/BSR20171175","article-title":"Prognostic Roles of Signal Transducers and Activators of Transcription Family in Human Breast Cancer","volume":"38","author":"Wang","year":"2018","journal-title":"Biosci. Rep."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20141293","article-title":"JAK2 Activation by Growth Hormone and Other Cytokines","volume":"466","author":"Waters","year":"2015","journal-title":"Biochem. J."},{"key":"B172","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"B173","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.3390\/cancers12092586","article-title":"Synergistic Anti-tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer","volume":"12","author":"Wen","year":"2020","journal-title":"Cancers"},{"key":"B174","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/annrheumdis-2016-210104","article-title":"Filgotinib (GLPG0634\/GS-6034), an Oral JAK1 Selective Inhibitor, Is Effective in Combination with Methotrexate (MTX) in Patients with Active Rheumatoid Arthritis and Insufficient Response to MTX: Results from a Randomised, Dose-Finding Study (DARWIN 1)","volume":"76","author":"Westhovens","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3390\/ijms20081808","article-title":"Curcumin: New Insights into an Ancient Ingredient against Cancer","volume":"20","author":"Willenbacher","year":"2019","journal-title":"Ijms"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/s41375-018-0117-x","article-title":"Implications of STAT3 and STAT5 Signaling on Gene Regulation and Chromatin Remodeling in Hematopoietic Cancer","volume":"32","author":"Wingelhofer","year":"2018","journal-title":"Leukemia"},{"key":"B177","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrrheum.2017.23","article-title":"The Emerging Safety Profile of JAK Inhibitors in Rheumatic Disease","volume":"13","author":"Winthrop","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cancers12010024","article-title":"Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity","volume":"12","author":"Wu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B179","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/jcm7080213","article-title":"Molecular Targets in Hepatocarcinogenesis and Implications for Therapy","volume":"7","author":"Wu","year":"2018","journal-title":"Jcm"},{"key":"B180","doi-asserted-by":"publisher","first-page":"106210","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The Role of JAK\/STAT Signaling Pathway and its Inhibitors in Diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int. Immunopharmacol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"112309","DOI":"10.1155\/2021\/7703159","article-title":"Effect of MiR-210 on the Chemosensitivity of Breast Cancer by Regulating JAK-STAT Signaling Pathway","volume":"2021","author":"Xing","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"B182","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting Cancer Stem Cell Pathways for Cancer Therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal. Transduct Target. Ther."},{"key":"B183","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrc2583","article-title":"Beyond Chemotherapy: Targeted Therapies in Ovarian Cancer","volume":"9","author":"Yap","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"B184","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/j.semcancer.2015.03.007","article-title":"Therapeutic Targeting of Replicative Immortality","volume":"35","author":"Yaswen","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"31690","DOI":"10.1038\/srep31690","article-title":"Epigenetic Silencing of the NR4A3 Tumor Suppressor, by Aberrant JAK\/STAT Signaling, Predicts Prognosis in Gastric Cancer","volume":"6","author":"Yeh","year":"2016","journal-title":"Sci. Rep."},{"key":"B186","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/jcb.29319","article-title":"LINC00346 Promotes Hepatocellular Carcinoma Progression via Activating the JAK-STAT3 Signaling Pathway","volume":"121","author":"Yin","year":"2020","journal-title":"J. Cel Biochem"},{"key":"B187","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.bbrc.2016.12.102","article-title":"MicroRNA-340 Inhibits the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting JAK1","volume":"483","author":"Yuan","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B188","doi-asserted-by":"publisher","first-page":"18848","DOI":"10.18632\/oncotarget.14473","article-title":"Co-ordinated Overexpression of SIRT1 and STAT3 Is Associated with Poor Survival Outcome in Gastric Cancer Patients","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"B189","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.tips.2011.11.002","article-title":"Targeting Src Family Kinases in Anti-cancer Therapies: Turning Promise into Triumph","volume":"33","author":"Zhang","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"B190","doi-asserted-by":"publisher","first-page":"107881","DOI":"10.1016\/j.pharmthera.2021.107881","article-title":"The Translational Values of TRIM Family in Pan-Cancers: from Functions and Mechanisms to Clinics","volume":"227","author":"Zhao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"B191","doi-asserted-by":"publisher","first-page":"31927","DOI":"10.18632\/oncotarget.5578","article-title":"A Novel Anti-cancer Agent Icaritin Suppresses Hepatocellular Carcinoma Initiation and Malignant Growth through the IL-6\/Jak2\/Stat3 Pathway","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"B192","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.1038\/onc.2016.124","article-title":"SUMOylation and SENP3 Regulate STAT3 Activation in Head and Neck Cancer","volume":"35","author":"Zhou","year":"2016","journal-title":"Oncogene"},{"key":"B193","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1038\/s41388-019-0843-1","article-title":"Activation of IGF1R by DARPP-32 Promotes STAT3 Signaling in Gastric Cancer Cells","volume":"38","author":"Zhu","year":"2019","journal-title":"Oncogene"},{"key":"B194","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/aps.2017.5","article-title":"New Knowledge of the Mechanisms of Sorafenib Resistance in Liver Cancer","volume":"38","author":"Zhu","year":"2017","journal-title":"Acta Pharmacol. Sin"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.821344\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:12:21Z","timestamp":1648516341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.821344\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":195,"alternative-id":["10.3389\/fphar.2022.821344"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.821344","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"article-number":"821344"}}